Document is current
Any future updates will be listed below
-
Authors
Moon, Donggyu
Hur, Seung-Ho https://orcid.org/0000-0002-3895-1915
Lee, Sang-Rok https://orcid.org/0000-0002-5845-2232
Jeong, Myung Ho https://orcid.org/0000-0003-2424-810X
Cho, Kyung Hoon https://orcid.org/0000-0002-0377-6352
Kwon, Osung https://orcid.org/0000-0001-6857-8632
Jeong, JinSeon https://orcid.org/0009-0008-4235-1040
Yoo, Ki Dong https://orcid.org/0000-0001-5425-1102
,
-
Funding
Funding for this research was provided by:
Amgen Korea
- License Information
-
More Information
Article History
Received: 27 May 2025
Accepted: 11 August 2025
First Online: 8 October 2025
Declarations
:
: JinSeon Jeong is an employee of Amgen. Kyung Hoon Cho has received an institutional research grant from Amgen; speaker/consulting honoraria from Amgen, Sanofi-Aventis, Viatris, Jeil Pharm, Aju Pharm, and JW Pharm. Donggyu Moon, Seung-Ho Hur, Sang-Rok Lee, Myung Ho Jeong, Osung Kwon, and Ki Dong Yoo declare no conflicts of interest.
: This study was approved by the Institutional Review Board at each study site (representatively, no. VC21OSDE0224 of the St Vincent's Hospital Ethics Review Committee), and the study was conducted in accordance with the Declaration of Helsinki. For a complete list of the ethics committees of participating hospitals, see the electronic supplementary file, Supplementary Material. All enrolled patients provided informed consent to participate in the study.
